It is worth noting that female carriers of CYBB-related CGD can exceptionally develop manifestations of CGD, as described in a recent case report of successful HSCT for a female carrier with severe life-threatening, late-onset granulomatous colitis and recurrent lung infections (Trevisan et al., 2022). Here, CYBB is linked to chronic granulomatous disease.